once weekly semaglutide in adults with alcohol use disorder Can help reduce craving and consumption alcohol disorder?, A randomized clinical trial published in JAMA Psychiatry offers preliminary evidence. , 🔗 Read the Low-dose semaglutide reduces alcohol consumption

Supervision, YZ

In ATTAIN-2 , which focused on patients with both obesity and type 2 diabetes, orforglipron 36 mg produced 10.5% weight loss compared to 2.2% with placebo, along with significant A1C reductions and improvements in cardiometabolic risk factors

When mere food intake seems inadequate, these injectables boost your energy and mood

GLP-1, short for glucagon-like peptide-1, is a hormone released in the small intestine after eating

Still, the pharma remains confident in the asset, with Gordon on Thursday playing up the paradigm-changing opportunity that MariTide presents in the obesity market

Men without baseline labs or medical supervision should not begin peptide therapy, because dosing and safety depend on health history, hormone levels, metabolic markers, and treatment goals